STING1 and pancreatic ductal adenocarcinoma: demonstrated that in pancreatic ductal adenocarcinoma tissues, the activation of the cyclic GMP-AMP synthase (cGAS)–STING pathway led to an increase in the markers of tumor-suppressing CAFs and the infiltration of tumor tissues by immune cells (34).